Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3193777 | Annals of Allergy, Asthma & Immunology | 2006 | 7 Pages |
Abstract
Anaphylaxis is a relatively common problem, affecting up to 2% of the population. Further data on epinephrine dispensing could improve current estimates. Another way to improve current understanding would be through better population-based study designs in different geographic regions. A recurring theme was the importance of broader access to self-injectable epinephrine for high-risk populations. An improved epidemiologic understanding of this disorder would aid ongoing efforts to reduce morbidity and mortality from anaphylaxis and could provide important clues for primary prevention.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Phil MD, Carlos A. MD, DrPH, Kari ScD, Hershel MD, Rachel L. MD, Aziz MD, F Estelle R. MD,